OXT and metabolic syndrome: This study aimed to explore the involvement of the oxytocinergic system as a possible pathophysiologic mechanism underlying OLZ-induced metabolic syndrome in a rodent model by, analyzing dose-dependent effects (OLZ), characterizing its biochemical features, and investigating OT’s therapeutic potential.